1. Home
  2. PICS vs NVAX Comparison

PICS vs NVAX Comparison

Compare PICS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$11.08

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$9.35

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PICS
NVAX
Founded
2012
1987
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PICS
NVAX
Price
$11.08
$9.35
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$23.00
$11.33
AVG Volume (30 Days)
622.9K
4.5M
Earning Date
03-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$135.00
N/A
Revenue Next Year
$39.69
N/A
P/E Ratio
$29.44
$3.71
Revenue Growth
N/A
64.69
52 Week Low
$10.30
$5.01
52 Week High
$18.49
$11.85

Technical Indicators

Market Signals
Indicator
PICS
NVAX
Relative Strength Index (RSI) 30.68 45.71
Support Level N/A $9.14
Resistance Level $15.83 $10.42
Average True Range (ATR) 1.21 0.55
MACD -0.36 -0.16
Stochastic Oscillator 15.08 3.97

Price Performance

Historical Comparison
PICS
NVAX

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: